SCHEMBL16219585

SCHEMBL16219585

COc1c(Br)cc2ccccc2c1-c1c(C(C)(C)C)c(Br)cc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ HPGD P15428 1/20 0.44
▸ NQO2 P16083 2/20 0.38
▸ MAPT P10636 2/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ERN1 O75460 1/20 0.35
▸ POLB P06746 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ EGFR P00533 1/20 0.34
▸ ERBB2 P04626 1/20 0.34
▸ MAPK14 Q16539 1/20 0.33
▸ PTGES O14684 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA4 P22748 1/20 0.33
▸ PDE1A P54750 1/20 0.32
▸ PDE1B Q01064 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31064790 0.87 ALDH1A1 (0.54) ALDH1A1KDM4ENPSR1HPGDNQO2
SCHEMBL3263989 0.87 ALDH1A1 (0.54) ALDH1A1KDM4ENPSR1HPGDNQO2
SCHEMBL14297112 0.84 ALDH1A1 (0.46) ALDH1A1KDM4ENPSR1HPGDNQO2
SCHEMBL16219583 0.80 ALDH1A1 (0.34) ALDH1A1KDM4EHPGDCYP2C19ALOX5
SCHEMBL16222420 0.80 ALDH1A1 (0.48) ALDH1A1KDM4ENPSR1HPGDNQO2
SCHEMBL16219575 0.78 ALDH1A1 (0.46) ALDH1A1KDM4ENPSR1HPGDMAPT
SCHEMBL14314326 0.78 KDM4E (0.46) ALDH1A1KDM4ENPSR1HPGDNQO2
SCHEMBL27905184 0.78 MAPT (0.67) ALDH1A1KDM4ENPSR1HPGDNQO2
SCHEMBL29227832 0.76 ALDH1A1 (0.48) ALDH1A1KDM4ENPSR1HPGDNQO2
SCHEMBL32677758 0.73 ALDH1A1 (0.45) ALDH1A1KDM4ENPSR1HPGDNQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9441059-B2 Metathesis catalysts and methods thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2016-09-13 — — US disclosed
US-20140378637-A1 METATHESIS CATALYSTS AND METHODS THEREOF NATIONAL SCIENCE FOUNDATION 2014-12-25 — — US disclosed
US-20140330018-A1 METATHESIS CATALYSTS AND METHODS THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2014-11-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140330018-A1 METATHESIS CATALYSTS AND METHODS THEREOF TERT, CYP19A1, MPO ALDH1A1 109/4885KDM4E 2110/4885NPSR1 2571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback